Search

everythinglearnresearchcommunity

for

Search:↓

The paper concludes that the 1982 criteria for diagnosing systemic lupus erythematosus need updating to improve accuracy and involve dermatologists in the process.

Pregnancy can change skin disease severity, with some conditions improving and others worsening, and treatment should balance benefits and fetal safety.

ALA-PDT is effective and safe for chronic X-ray dermatitis, providing complete or partial remission.

Minoxidil, a common hair loss treatment, might work by counteracting a hormone that reduces hair growth and promotes hair loss.

Minoxidil improved rat skin flap survival but was less effective than surgical methods.

Eosinophilia-myalgia syndrome, linked to contaminated L-tryptophan supplements, caused severe symptoms and some deaths, with long-term effects in survivors.

A patient with Rhupus was diagnosed with Rowell syndrome and treated with various medications.

A fungus ball in the lung can cause coughing up blood in SLE patients.

A girl with hereditary chorea, likely Huntington's disease, had her condition worsened by lupus.

Tattoos may trigger autoimmune symptoms in some people.

Trans-esophageal echocardiography is crucial for accurately diagnosing heart issues in lupus patients.

An imbalanced scalp microbiome may worsen alopecia areata severity and inflammation, but treatment can partially restore balance.

Continuous glucose monitoring and GLP-1 receptor agonists improve diabetes management, but personalized care and education are crucial.

Fever and rash can be early signs of lupus.

The article concludes that schoolchildren and adolescents experienced various skin issues during the COVID-19 pandemic, including acne from masks and other skin reactions from the virus and vaccines.

The meeting showcased rare skin disease cases, highlighting the need for accurate diagnosis and treatment.

UK medical students lack dermatology education, liver biopsy patients with risk factors show more fibrosis, and certain fungi resist drugs due to melanin; genetics may influence female hair loss.

The document concludes that there is a need for more research and regulation in dermatology, covering topics like latex allergy in children, the use of botulinum toxin, and treatments for skin conditions.

Scientists made the first metal-based compounds from a nonsteroidal antiandrogen drug, which showed potential in fighting both hormone-dependent and independent prostate cancer cells.

S5αR inhibitors might help treat schizophrenia and other mental disorders but need more research.

Finasteride reduces hair loss and treats BPH without major hormone changes, but may cause sexual dysfunction.

RU 58841 may treat acne, hair loss, and excessive hair growth.

DHEA did not improve sexual function, well-being, or menopausal symptoms in postmenopausal women with low libido but caused side effects like acne and increased facial hair.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

The composition with carnitine, thioctic acid, and saw palmetto extract may effectively reduce inflammation in hair follicle cells.

Spironolactone, a heart and liver drug, has new uses including cancer treatment, viral infection prevention, and skin condition improvement.

Iron oxide nanoparticles improve skin penetration and drug release for hair loss treatment.

Skin conditions can signal heart issues, highlighting the need for integrated care.

Using two drugs together, Flutamide and 4-MA, is more effective for blocking male hormones than using each one alone.

Saw palmetto supplements may modestly improve hair regrowth with few side effects, but more research is needed.